Amphastar Pharmaceuticals (AMPH) vs Harrow (HROW)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Amphastar Pharmaceuticals (AMPH) has outperformed Harrow (HROW) over the past year, losing 1.1% versus a loss of 26.9%. Over five years, HROW leads with a +209.6% price change compared with +33.6% for AMPH. Harrow is the larger company by market cap ($1.15 billion vs $1.09 billion), about 1.1 times the size.
On valuation, Amphastar Pharmaceuticals trades at a lower forward P/E (8.0x vs 11.0x for Harrow).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AMPH | HROW |
|---|---|---|
| Share price | $25.54 | $30.62 |
| Market cap | $1.09B | $1.15B |
| 1-day change | -1.43% | +0.89% |
| YTD return | -4.63% | -37.51% |
| 1-year return | -1.12% | -26.92% |
| 5-year return | +33.65% | +209.61% |
| P/E ratio (TTM) | 15.11 | — |
| Forward P/E | 8.03 | 11.04 |
| EPS (TTM) | $1.69 | $-0.99 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $29.52 | $54.85 |
| 52-week low | $16.65 | $28.54 |
| Distance from 52-week high | -13.48% | -44.18% |
| Average volume | 467.79K | 552.72K |
| Shares outstanding | 42.54M | 37.49M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AMPH has outperformed HROW by 25.8 percentage points over the past year.
AMPH vs HROW FAQ
Which is bigger, Amphastar Pharmaceuticals or Harrow?
Harrow (HROW) is larger, with a market capitalization of $1.15B compared with $1.09B for Amphastar Pharmaceuticals (AMPH).
Which stock has performed better over the past year, AMPH or HROW?
AMPH returned -1.12% over the past 12 months, compared with -26.92% for HROW (price return, excluding dividends). Past performance does not predict future results.
Are Amphastar Pharmaceuticals and Harrow in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.